SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122397
Filing Date
2019-04-26
Accepted
2019-04-26 16:18:04
Documents
7
Period of Report
2019-06-06
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d668722ddef14a.htm DEF 14A 655423
2 GRAPHIC g668722g07j96.jpg GRAPHIC 28383
3 GRAPHIC g668722g17v71.jpg GRAPHIC 18671
4 GRAPHIC g668722g25w26.jpg GRAPHIC 55629
5 GRAPHIC g668722g29h98.jpg GRAPHIC 22894
6 GRAPHIC g668722g29t38.jpg GRAPHIC 18671
7 GRAPHIC g668722g96y28.jpg GRAPHIC 79966
  Complete submission text file 0001193125-19-122397.txt   965756
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35347 | Film No.: 19771986
SIC: 2834 Pharmaceutical Preparations